Aureobasidium.org

In Vitro 2011

Hepatitis C Virus NS3 Protein Can Activate the Notch-Signaling Pathway through Binding to a Transcription Factor, SRCAP

Iwai A., Takegami T., Shiozaki T., Miyazaki T. · PLoS ONE · DOI: 10.1371/journal.pone.0020718
Research Archive
TL;DR — Key Findings
  • HCV NS3 altered Notch-related signaling in a cell model.
  • SRCAP and p400 contributed to the observed transcriptional effect.
  • The paper has no direct beta-glucan or Aureobasidium experiment.

Abstract

This cell-based study found that hepatitis C virus NS3 protein bound the transcriptional regulators SRCAP and p400 and increased Notch-responsive Hes-1 promoter activity in Hep3B cells. Reducing SRCAP and p400 expression weakened that response, suggesting a possible pathway connecting persistent HCV infection with altered host-cell signaling. The paper did not investigate beta-glucan or Aureobasidium pullulans; its relevance to this archive is indirect background on viral pathogenesis.

Summary

Summary

What was studied

The interaction of hepatitis C virus NS3 protein with SRCAP, p400, and Notch-related transcription in liver-derived cells.

What was observed

NS3 bound SRCAP and p400 and increased Hes-1 promoter activity; combined silencing reduced the response.

How to interpret it

This is cell-based viral-pathogenesis research. It did not study beta-glucan or Aureobasidium pullulans.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Iwai A., Takegami T., Shiozaki T., Miyazaki T.. Hepatitis C Virus NS3 Protein Can Activate the Notch-Signaling Pathway through Binding to a Transcription Factor, SRCAP. PLoS ONE. 2011. DOI: 10.1371/journal.pone.0020718.

Study Details
Study Type
In Vitro
Published
2011
Journal
PLoS ONE
Authors
Iwai A., Takegami T., Shiozaki T., Miyazaki T.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.